Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by William A. Garland
Anti-Tumor Effects of an Id Antagonist With No Acquired Resistance
Related publications
P1.13-13 Potent Anti-Tumor Effect of Ganetespib in Acquired EGFR-TKI Resistance NSCLC Cells
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Evolution of Acquired Resistance to Anti-Cancer Therapy
Journal of Theoretical Biology
Statistics
Genetics
Probability
Molecular Biology
Biochemistry
Applied Mathematics
Microbiology
Simulation
Immunology
Biological Sciences
Medicine
Agricultural
Modeling
Efficacy of Sym004 in Patients With Metastatic Colorectal Cancer With Acquired Resistance to Anti-Egfr Therapy and Molecularly Selected by Circulating Tumor DNA Analyses
JAMA Oncology
Cancer Research
Oncology
Introduction of theCIITAgene Into Tumor Cells Produces Exosomes With Enhanced Anti-Tumor Effects
Experimental and Molecular Medicine
Biochemistry
Medicine
Clinical Biochemistry
Molecular Biology
Molecular Medicine
WL-276, an Antagonist Against BCL-2 Proteins, Overcomes Drug Resistance and Suppresses Prostate Tumor Growth
Cancer Research
Cancer Research
Oncology
ACE2 Overexpression Inhibits Acquired Platinum Resistance-Induced Tumor Angiogenesis in NSCLC
Oncology Reports
Medicine
Cancer Research
Oncology
Tumor Localization of an Anti-TGF-Β Antibody and Its Effects on Gliomas
International Journal of Oncology
Cancer Research
Oncology
RACK1 Overexpression Is Linked to Acquired Imatinib Resistance in Gastrointestinal Stromal Tumor
Oncotarget
Oncology
Endocrine Delivery System of NK4, an HGF-Antagonist and Anti-Angiogenic Regulator, for Inhibitions of Tumor Growth, Invasion and Metastasis